Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.

Vasquez R, Wang D, Tran QP, Adams-Huet B, Chren MM, Costner MI, Cohen JB, Werth VP, Chong BF.

Br J Dermatol. 2013 Jan;168(1):145-53. doi: 10.1111/j.1365-2133.2012.11106.x. Epub 2012 Sep 13.

2.

The impact of skin damage due to cutaneous lupus on quality of life.

Verma SM, Okawa J, Propert KJ, Werth VP.

Br J Dermatol. 2014 Feb;170(2):315-21. doi: 10.1111/bjd.12653.

3.

A quality-of-life study of cutaneous lupus erythematosus.

Batalla A, García-Doval I, Peón G, de la Torre C.

Actas Dermosifiliogr. 2013 Nov;104(9):800-6. doi: 10.1016/j.ad.2013.04.005. Epub 2013 Jun 17. English, Spanish.

PMID:
23787361
4.

Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.

Moghadam-Kia S, Chilek K, Gaines E, Costner M, Rose ME, Okawa J, Werth VP.

Arch Dermatol. 2009 Mar;145(3):255-60. doi: 10.1001/archdermatol.2008.594.

5.

Characterization of clinical photosensitivity in cutaneous lupus erythematosus.

Foering K, Chang AY, Piette EW, Cucchiara A, Okawa J, Werth VP.

J Am Acad Dermatol. 2013 Aug;69(2):205-13. doi: 10.1016/j.jaad.2013.03.015. Epub 2013 May 3.

6.

Photoprotective habits of patients with cutaneous lupus erythematosus.

Yang SY, Bernstein I, Lin DQ, Chong BF.

J Am Acad Dermatol. 2013 Jun;68(6):944-51. doi: 10.1016/j.jaad.2012.11.016. Epub 2013 Jan 27.

7.

Pain and pruritus in cutaneous lupus: their association with dermatologic quality of life and disease activity.

Méndez-Flores S, Orozco-Topete R, Bermúdez-Bermejo P, Hernández-Molina G.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):940-2. Epub 2013 Aug 2.

PMID:
23981524
8.

Quality of life in cutaneous lupus erythematosus.

Klein R, Moghadam-Kia S, Taylor L, Coley C, Okawa J, LoMonico J, Chren MM, Werth VP.

J Am Acad Dermatol. 2011 May;64(5):849-58. doi: 10.1016/j.jaad.2010.02.008. Epub 2011 Mar 12.

9.

Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.

Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ Jr, Matteson EL, Maradit Kremers H, Chowdhary VR.

Arthritis Care Res (Hoboken). 2015 May;67(6):817-28. doi: 10.1002/acr.22502.

10.

Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.

Grönhagen CM, Fored CM, Granath F, Nyberg F.

Br J Dermatol. 2011 Jun;164(6):1335-41. doi: 10.1111/j.1365-2133.2011.10272.x. Epub 2011 May 17.

PMID:
21574972
11.

Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).

Biazar C, Sigges J, Patsinakidis N, Ruland V, Amler S, Bonsmann G, Kuhn A; EUSCLE co-authors.

Autoimmun Rev. 2013 Jan;12(3):444-54. doi: 10.1016/j.autrev.2012.08.019. Epub 2012 Sep 18.

PMID:
23000206
12.

Impact of smoking in cutaneous lupus erythematosus.

Piette EW, Foering KP, Chang AY, Okawa J, Ten Have TR, Feng R, Werth VP.

Arch Dermatol. 2012 Mar;148(3):317-22. doi: 10.1001/archdermatol.2011.342. Epub 2011 Nov 21. Erratum in: Arch Dermatol. 2012 Dec;148(12):1369.

13.

Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan.

Ishiguro M, Hashizume H, Ikeda T, Yamamoto Y, Furukawa F.

Lupus. 2014;23(1):93-101. doi: 10.1177/0961203313509293. Epub 2013 Nov 6.

PMID:
24197553
14.

Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.

Szepietowski JC, Nilganuwong S, Wozniacka A, Kuhn A, Nyberg F, van Vollenhoven RF, Bengtsson AA, Reich A, de Vries DE, van Hartingsveldt B, Robinson DW Jr, Gordon R, Hsu B.

Arthritis Rheum. 2013 Oct;65(10):2661-71. doi: 10.1002/art.38091.

16.

Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.

Fernandez-Peñas P, Jones-Caballero M, Espallardo O, García-Díez A.

Br J Dermatol. 2012 Apr;166(4):884-7. doi: 10.1111/j.1365-2133.2012.10806.x.

PMID:
22229951
17.

Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.

Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S, Bonsmann G; EUSCLE coauthors.

Br J Dermatol. 2014 Sep;171(3):571-9. doi: 10.1111/bjd.13006. Epub 2014 Aug 25.

PMID:
24673427
18.

Prevalence of self-report photosensitivity in cutaneous lupus erythematosus.

Foering K, Goreshi R, Klein R, Okawa J, Rose M, Cucchiara A, Werth VP.

J Am Acad Dermatol. 2012 Feb;66(2):220-8. doi: 10.1016/j.jaad.2010.12.006. Epub 2011 Jul 13.

19.

Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features.

Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR.

Semin Arthritis Rheum. 1992 Feb;21(4):221-6. Review.

PMID:
1570517
20.

Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus.

Wieczorek IT, Propert KJ, Okawa J, Werth VP.

JAMA Dermatol. 2014 Mar;150(3):291-6. doi: 10.1001/jamadermatol.2013.9026.

PMID:
24477339

Supplemental Content

Support Center